Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-105,216
Closed -$2.3M 948
2020
Q4
$2.3M Sell
105,216
-85,300
-45% -$1.4M 0.01% 655
2020
Q3
$2.24M Sell
190,516
-15,421
-7% -$192K 0.01% 734
2020
Q2
$2.35M Sell
205,937
-130,126
-39% -$1.47M 0.01% 615
2020
Q1
$3.75M Buy
336,063
+210,381
+167% +$2.94M 0.03% 511
2019
Q4
$2.01M Buy
+125,682
New +$1.86M 0.01% 708

Other funds holding CDXS

Aviva's CDXS Position: Q1 2021 in Review

Aviva sold out of Codexis (CDXS) in Q1 2021, closing a stake of 105,216 shares — an estimated $2.3M sold.

Aviva first reported a position in CDXS in Q4 2019 and held it in 5 quarters. The position peaked at $3.75M in Q1 2020. 151 funds tracked by Wall St. Rank hold CDXS as of Q1 2021.

  • Aviva reported no remaining Codexis position as of Q1 2021 after selling out during the quarter.
  • Aviva sold 105,216 Codexis shares in Q1 2021, an estimated $2.3M.
  • Aviva first reported a position in Codexis in Q4 2019 and held it in 5 quarters.
  • Aviva's Codexis position peaked at $3.75M in Q1 2020.
  • 151 funds tracked by Wall St. Rank held Codexis as of Q1 2021.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.